Who Owns Biogen Stock?
NASDAQ: BIIBHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 100.37%
- Institutions (% of float)
- 100.58%
- Held by insiders
- 0.21%
- Institutional holders
- 1,525
- Institutions 99.8%
- Insiders 0.2%
- Public and other 0.0%
Who owns Biogen stock?
Institutional investors own about 100.4% of Biogen's shares, spread across 1,525 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.21% of BIIB.
The largest institutional holders are FMR, LLC (11.35%), Blackrock Inc. (10.88%) and Primecap Management Company (10.28%). Together, the top 10 institutions control 57.5% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their BIIB positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of BIIB
| Institution | Shares | % Held | Change |
|---|---|---|---|
| FMR, LLC | 16.78M | 11.35% | -7.9% |
| Blackrock Inc. | 16.09M | 10.88% | +0.7% |
| Primecap Management Company | 15.20M | 10.28% | +0.3% |
| Vanguard Capital Management LLC | 9.67M | 6.54% | +0.2% |
| State Street Corporation | 7.56M | 5.12% | +3.0% |
| Vanguard Portfolio Management LLC | 6.57M | 4.45% | -0.5% |
| Geode Capital Management, LLC | 4.51M | 3.05% | +1.3% |
| Wellington Management Group, LLP | 3.46M | 2.34% | +10.9% |
| NORGES BANK | 2.58M | 1.75% | -2.2% |
| Morgan Stanley | 2.51M | 1.70% | +4.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of BIIB
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD CHESTER FUNDS-Vanguard PRIMECAP Fund | 8.36M | 5.66% |
| Fidelity Contrafund | 5.23M | 3.54% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 4.69M | 3.17% |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 3.83M | 2.59% |
| VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund | 3.20M | 2.16% |
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 2.75M | 1.86% |
| VANGUARD HORIZON FUNDS-Vanguard Capital Opportunity Fund | 2.62M | 1.78% |
| iShares Trust-iShares Core S&P 500 ETF | 1.97M | 1.33% |
| Fidelity Concord Street Trust-Fidelity 500 Index Fund | 1.92M | 1.30% |
| SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust | 1.83M | 1.24% |
Frequently asked questions
Who is the largest shareholder of Biogen?
FMR, LLC is the largest institutional shareholder of BIIB, owning 11.35% of shares outstanding (16.78M shares) as of its latest 13F filing.
What percentage of Biogen is owned by institutions?
Institutions own about 100.4% of BIIB shares and 100.6% of the public float.
How much of Biogen do insiders own?
Insiders, such as officers and directors, own about 0.21% of BIIB shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.